Show
Sort by
-
- Journal Article
- A1
- open access
Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19
-
- Journal Article
- A1
- open access
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients : DAWn-plasma
-
Reply to 'The perceived efficacy of hydroxychloroquine in observational studies : the results of the confounding effects of goals of care'
-
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial
-
- Journal Article
- A1
- open access
The human fetal thymus generates invariant effector γδ T cells
-
- Journal Article
- A1
- open access
A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19 : the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
-
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19 : a nationwide observational study of 8075 participants
-
Clinical work in language-discordant Emergency Department consultations